Eva Agneta Edberg

Eva Agneta Edberg currently works at CathPrint AB, as Chairman, A Edberg Consulting AB, as Chairman from 2010, Idogen AB, as Chairman, Apotek Produktion & Laboratorier AB, as Director, Temperature Sensitive Solutions AB, as Director, UBC Ekonomisk Förvaltning i Sverige AB, as Director from 2008, XNK Therapeutics AB, as Director from 2018, Temperature Sensitive Solutions Systems Sweden AB, as Director, Elicera Therapeutics AB, as Independent Director from 2026, Stiftelsen Start Up Life Science, as Director, Centre For Advanced Medical Products, as Director, and Nextgennk, as Director.
Ms. Edberg also formerly worked at Cederroth AB, as Chief Executive Officer, NM Pharma AS, as Chief Executive Officer, LFF Service AB, as Chief Executive Officer, Farmos Group AB, as Chief Executive Officer, Cilag AB, as Chief Executive Officer, Mylan AB, as Chief Executive Officer from 2011 to 2013, Scand Pharm Marketing AB, as Chairman & Chief Executive Officer, Cederroth International AB, as Chief Executive Officer, A+ Science AB, as Chairman, BioResonator AB, as Chairman, Likvor AB, as Chairman, Scandinavian Pharmaceuticals-Generics AB, as Chairman, Ambulanssjukvården i Storstockholm AB, as Chairman, Biomatcell AB, as Chairman, Mendus AB, as Chairman from 2010 to 2018, BioResonator Good Eye AB, as Chairman, Health Solutions AB, as Chairman, Probac AB, as Director, Swedish Pharmaceutical Insurance Association, as Director, Svenska Läkemedelsförsäkringen AB, as Director, Profarina AB, as Director, Nabolaget AB, as Director, Fastum AB, as Director, TSS Holdings Sweden AB, as Director, Pfizer Inc., as Principal, Pharmacia AB, as Principal, CareDx International AB, as Chief Operating Officer, Hansen Conference & Event AB, as Principal, Bactiguard AB, as Vice President in 2006, and Recopharma AB, as Chief Operating Officer from 2008 to 2009.
Ms. Edberg received her undergraduate degree from Stockholm School of Economics and undergraduate degree from the University of Mid Sweden.